Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.21 | N/A | +3.07% |
management commentary, guidance changes, and full analysis available with Pro.
| +3.07% |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results despite not providing revenue figures. They acknowledged ongoing challenges but emphasized a commitment to growth.
We are pleased with our EPS performance this quarter.
While we face some challenges, we remain focused on our long-term growth strategy.
Agilent Technologies reported a better-than-expected EPS for the quarter, which indicates strong profitability. However, the stock reacted negatively, declining by 1.18%. The lack of revenue information and guidance may have contributed to investor uncertainty.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
TELADOC HEALTH INC
Feb 22, 2022